ISDA

Deposition Date 2008-06-06

Release Date 2009-01-27

Last Version Date 2023-08-30

Entry Detail

PDB ID:

3DDW

Keywords:

TRANSFERASE

Title:

Crystal structure of glycogen phosphorylase complexed with an anthranilimide based inhibitor GSK055

Biological Source:

Source Organism:

Homo sapiens (Taxon ID: 9606)

Host Organism:

Escherichia coli

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

1.90 Å

R-Value Free:

0.18

R-Value Work:

0.15

R-Value Observed:

0.15

Space Group:

P 31

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Molecule:Glycogen phosphorylase, liver form
Gene (Uniprot):PYGL
Chain IDs:A, B
Chain Length:848
Number of Molecules:2
Biological Source:Homo sapiens

UniProt ID:P06737 Pfam ID:PF00343 EC:2.4.1.1

Modified Residue

Compound ID	Chain ID	Parent Comp ID	Details	2D Image
SEP	A	SER	PHOSPHOSERINE

Ligand Molecules

055

CFF

MES

MPD

NBG

PLP

Primary Citation

Anthranilimide based glycogen phosphorylase inhibitors for the treatment of type 2 diabetes. Part 3: X-ray crystallographic characterization, core and urea optimization and in vivo efficacy.

Thomson, S.A, Banker, P, Bickett, D.M, Boucheron, J.A, Carter, H.L, Clancy, D.C, Cooper, J.P, Dickerson, S.H, Garrido, D.M, Nolte, R.T, Peat, A.J, Sheckler, L.R, Sparks, S.M, Tavares, F.X, Wang, L, Wang, T.Y, Weiel, J.E.Show

Bioorg.Med.Chem.Lett. 19 1177 1182 (2009)

PMID: 19138846 DOI: 10.1016/j.bmcl.2008.12.085

Abstact

Key binding interactions of the anthranilimide based glycogen phosphorylase a (GPa) inhibitor 2 from X-ray crystallography studies are described. This series of compounds bind to the AMP site of GP. Using the binding information the core and the phenyl urea moieties were optimized. This work culminated in the identification of compounds with single nanomolar potency as well as in vivo efficacy in a diabetic model.

Legend

Protein

Chemical

Disease

Primary Citation of related structures